STAAR SURGICAL CO — Director's Dealing 2021

May 12, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: STAAR SURGICAL CO (STAA)
CIK: 0000718937
Period of Report: 2021-05-10

Reporting Person: Hayashida Jon K. (VP, Global Clinical, Medical)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-05-10	Common Stock	S	1349	$125.22	Disposed	8342	Direct
2021-05-10	Common Stock	M	7200	$16.15	Acquired	15542	Direct
2021-05-10	Common Stock	M	2534	$29.80	Acquired	18076	Direct
2021-05-10	Common Stock	M	3462	$35.98	Acquired	21538	Direct
2021-05-10	Common Stock	M	5523	$27.53	Acquired	27061	Direct
2021-05-10	Common Stock	S	10760	$124.13	Disposed	16301	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-05-10	Common Stock Options	$16.15	M	7200	Disposed	2028-03-14	Common Stock (7200)	Direct
2021-05-10	Common Stock Options	$29.80	M	2534	Disposed	2028-06-13	Common Stock (2534)	Direct
2021-05-10	Common Stock Options	$35.98	M	3462	Disposed	2029-03-13	Common Stock (3462)	Direct
2021-05-10	Common Stock Options	$27.53	M	5523	Disposed	2030-03-19	Common Stock (5523)	Direct

Footnotes

F1: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $111.02 to $135.64, inclusive.

F2: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $110.85 to $135.64, inclusive.

F3: The options granted become exercisable as follows: 1/3 on 3/15/2019 and the remaining 2/3 of such options shall become exercisable over the following 24 months in equal amounts on a monthly basis. In the event the options do not evenly divide into 24 months, the remaining balance of options granted shall become exercisable on 3/15/2028.

F4: The options granted become exercisable as follows: 1/3 on 6/14/2019 and the remaining 2/3 of such options shall become exercisable over the following 24 months in equal amounts on a monthly basis. In the event the options do not evenly divide into 24 months, the remaining balance of options granted shall become exercisable on 6/14/2028.

F5: The options granted become exercisable as follows: 1/3 on 3/14/2020 and the remaining 2/3 of such options shall become exercisable over the following 24 months in equal amounts on a monthly basis. In the event the options do not evenly divide into 24 months, the remaining balance of options granted shall become exercisable on 3/14/2022.

F6: The options granted become exercisable as follows: 1/3 on 3/20/2021 and the remaining 2/3 of such options shall become exercisable over the following 24 months in equal amounts on a monthly basis. In the event the options do not evenly divide into 24 months, the remaining balance of options granted shall become exercisable on 3/20/2023.